Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations.

Han Q, Jones JA, Nicely NI, Reed RK, Shen X, Mansouri K, Louder M, Trama AM, Alam SM, Edwards RJ, Bonsignori M, Tomaras GD, Korber B, Montefiori DC, Mascola JR, Seaman MS, Haynes BF, Saunders KO.

Nat Commun. 2019 Jul 1;10(1):2898. doi: 10.1038/s41467-019-10899-2.

2.

Joining forces for pediatric very rare tumors.

Ferrari A, Schneider DT, Bisogno G, Trama A.

Oncotarget. 2019 May 3;10(33):3084-3085. doi: 10.18632/oncotarget.26871. eCollection 2019 May 3. No abstract available.

3.

The European study on centralisation of childhood cancer treatment.

Gatta G, Botta L, Comber H, Dimitrova N, Leinonen MK, Pritchard-Jones K, Siesling S, Trama A, Van Eycken L, van der Zwan JM, Visser O, Zagar T, Capocaccia R.

Eur J Cancer. 2019 Jul;115:120-127. doi: 10.1016/j.ejca.2019.04.024. Epub 2019 May 24.

PMID:
31132742
4.

Excess risk of dying of other causes of cured cancer patients.

Botta L, Gatta G, Trama A, Capocaccia R.

Tumori. 2019 Jun;105(3):199-204. doi: 10.1177/0300891619837896. Epub 2019 Mar 25.

PMID:
30905274
5.

Soft tissue sarcoma in Italy: From epidemiological data to clinical networking to improve patient care and outcomes.

Trama A, Badalamenti G, Baldi GG, Brunello A, Caira M, Drove N, Marrari A, Palmerini E, Vincenzi B, Dei Tos AP, Grignani G.

Cancer Epidemiol. 2019 Apr;59:258-264. doi: 10.1016/j.canep.2019.02.012. Epub 2019 Mar 11. Review.

6.

Cancer of the anal region.

Valvo F, Ciurlia E, Avuzzi B, Doci R, Ducreux M, Roelofsen F, Roth A, Trama A, Wittekind C, Bosset JF.

Crit Rev Oncol Hematol. 2019 Mar;135:115-127. doi: 10.1016/j.critrevonc.2018.12.007. Epub 2019 Jan 16. Review.

PMID:
30819440
7.

Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors.

Ferrari A, Brecht IB, Gatta G, Schneider DT, Orbach D, Cecchetto G, Godzinski J, Reguerre Y, Bien E, Stachowicz-Stencel T, Ost M, Magni C, Kearns P, Vassal G, Massimino M, Biondi A, Bisogno G, Trama A.

Eur J Cancer. 2019 Mar;110:120-126. doi: 10.1016/j.ejca.2018.12.031. Epub 2019 Feb 19.

PMID:
30785015
8.

Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies.

Henderson R, Watts BE, Ergin HN, Anasti K, Parks R, Xia SM, Trama A, Liao HX, Saunders KO, Bonsignori M, Wiehe K, Haynes BF, Alam SM.

Nat Commun. 2019 Feb 8;10(1):654. doi: 10.1038/s41467-019-08415-7.

9.

Incidence of rare cancers in the city of São Paulo, Brazil.

Bustamante-Teixeira MT, Latorre MDRDO, Guerra MR, Tanaka LF, Botta L, Trama A, Gatta G.

Tumori. 2019 Feb;105(1):22-30. doi: 10.1177/0300891618821039. Epub 2019 Jan 30.

PMID:
30700226
10.

Chordoma: update on disease, epidemiology, biology and medical therapies.

Frezza AM, Botta L, Trama A, Dei Tos AP, Stacchiotti S.

Curr Opin Oncol. 2019 Mar;31(2):114-120. doi: 10.1097/CCO.0000000000000502.

PMID:
30585858
11.

Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.

Kisalu NK, Idris AH, Weidle C, Flores-Garcia Y, Flynn BJ, Sack BK, Murphy S, Schön A, Freire E, Francica JR, Miller AB, Gregory J, March S, Liao HX, Haynes BF, Wiehe K, Trama AM, Saunders KO, Gladden MA, Monroe A, Bonsignori M, Kanekiyo M, Wheatley AK, McDermott AB, Farney SK, Chuang GY, Zhang B, Kc N, Chakravarty S, Kwong PD, Sinnis P, Bhatia SN, Kappe SHI, Sim BKL, Hoffman SL, Zavala F, Pancera M, Seder RA.

Nat Med. 2019 Jan;25(1):188-189. doi: 10.1038/s41591-018-0315-0.

PMID:
30552419
12.

Cancer Burden in Adolescents and Young Adults: A Review of Epidemiological Evidence.

Trama A, Botta L, Steliarova-Foucher E.

Cancer J. 2018 Nov/Dec;24(6):256-266. doi: 10.1097/PPO.0000000000000346.

PMID:
30480570
13.

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME).

Imbimbo M, Ottaviano M, Vitali M, Fabbri A, Leuzzi G, Fiore M, Franceschini D, Pasello G, Perrino M, Schiavon M, Pruneri G, Dei Tos AP, Sangalli C, Garassino MC, Berardi R, Alessi A, Calareso G, Petrini I, Scorsetti M, Scotti V, Rosso L, Rea F, Pastorino U, Casali PG, Ramella S, Ricardi U, Abate-Daga L, Torri V, Trama A, Palmieri G, Marino M, Zucali PA; TYME network collaborators.

Cancer Treat Rev. 2018 Dec;71:76-87. doi: 10.1016/j.ctrv.2018.10.001. Epub 2018 Oct 5.

PMID:
30366202
14.

Big Data in Head and Neck Cancer.

Resteghini C, Trama A, Borgonovi E, Hosni H, Corrao G, Orlandi E, Calareso G, De Cecco L, Piazza C, Mainardi L, Licitra L.

Curr Treat Options Oncol. 2018 Oct 25;19(12):62. doi: 10.1007/s11864-018-0585-2. Review.

PMID:
30361937
15.

Survival of adults with cancers of bone or soft tissue in Europe-Report from the EUROCARE-5 study.

Stiller CA, Botta L, Brewster DH, Ho VKY, Frezza AM, Whelan J, Casali PG, Trama A, Gatta G; EUROCARE-5 Working Group.

Cancer Epidemiol. 2018 Oct;56:146-153. doi: 10.1016/j.canep.2018.08.010. Epub 2018 Sep 1.

PMID:
30179828
16.

Is the cancer survival improvement in European and American adolescent and young adults still lagging behind that in children?

Trama A, Bernasconi A, McCabe MG, Guevara M, Gatta G, Botta L; RARECAREnet Working Group, Ries L, Bleyer A.

Pediatr Blood Cancer. 2019 Jan;66(1):e27407. doi: 10.1002/pbc.27407. Epub 2018 Aug 19. Review.

PMID:
30124231
17.

RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma.

Imbimbo M, Vitali M, Fabbri A, Ottaviano M, Pasello G, Petrini I, Palmieri G, Berardi R, Zucali P, Ganzinelli M, Marabese M, Broggini M, Marino M, Trama A, Rulli E, Hollander L, Pruneri G, Torri V, Garassino MC.

Clin Lung Cancer. 2018 Sep;19(5):e811-e814. doi: 10.1016/j.cllc.2018.06.005. Epub 2018 Jul 3.

PMID:
30033090
18.

Networking in rare cancers: What was done, what's next.

Frezza AM, Trama A, Blay JY, Casali PG.

Eur J Surg Oncol. 2019 Jan;45(1):16-18. doi: 10.1016/j.ejso.2018.03.030. Epub 2018 Apr 12.

PMID:
29685758
19.

Bayesian estimates of the incidence of rare cancers in Europe.

Botta L, Capocaccia R, Trama A, Herrmann C, Salmerón D, De Angelis R, Mallone S, Bidoli E, Marcos-Gragera R, Dudek-Godeau D, Gatta G, Cleries R; RARECAREnet Working group.

Cancer Epidemiol. 2018 Jun;54:95-100. doi: 10.1016/j.canep.2018.04.003. Epub 2018 Apr 21.

PMID:
29684802
20.

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.

Pusceddu S, Barretta F, Trama A, Botta L, Milione M, Buzzoni R, De Braud F, Mazzaferro V, Pastorino U, Seregni E, Mariani L, Gatta G, Di Bartolomeo M, Femia D, Prinzi N, Coppa J, Panzuto F, Antonuzzo L, Bajetta E, Brizzi MP, Campana D, Catena L, Comber H, Dwane F, Fazio N, Faggiano A, Giuffrida D, Henau K, Ibrahim T, Marconcini R, Massironi S, Žakelj MP, Spada F, Tafuto S, Van Eycken E, Van der Zwan JM, Žagar T, Giacomelli L, Miceli R; NEPscore Working Group.

Endocr Relat Cancer. 2018 Jun;25(6):607-618. doi: 10.1530/ERC-17-0489. Epub 2018 Mar 20.

21.

A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.

Kisalu NK, Idris AH, Weidle C, Flores-Garcia Y, Flynn BJ, Sack BK, Murphy S, Schön A, Freire E, Francica JR, Miller AB, Gregory J, March S, Liao HX, Haynes BF, Wiehe K, Trama AM, Saunders KO, Gladden MA, Monroe A, Bonsignori M, Kanekiyo M, Wheatley AK, McDermott AB, Farney SK, Chuang GY, Zhang B, Kc N, Chakravarty S, Kwong PD, Sinnis P, Bhatia SN, Kappe SHI, Sim BKL, Hoffman SL, Zavala F, Pancera M, Seder RA.

Nat Med. 2018 May;24(4):408-416. doi: 10.1038/nm.4512. Epub 2018 Mar 19. Erratum in: Nat Med. 2019 Jan;25(1):188-189.

22.

Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference.

Nicolai N, Biasoni D, Catanzaro MA, Colecchia M, Trama A; RARECAREnet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):60-66. doi: 10.1016/j.ejso.2018.02.006. Epub 2018 Feb 14. Review.

PMID:
29526370
23.

Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?

Minicozzi P, Walsh PM, Sánchez MJ, Trama A, Innos K, Marcos-Gragera R, Dimitrova N, Botta L, Johannesen TB, Rossi S, Sant M; EUROCARE-5 Working Group.

Eur J Cancer. 2018 Apr;93:127-137. doi: 10.1016/j.ejca.2018.01.084. Epub 2018 Mar 20.

PMID:
29518726
24.

Treatment challenges in and outside a network setting: Head and neck cancers.

Orlandi E, Alfieri S, Simon C, Trama A, Licitra L; RARECAREnet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):40-45. doi: 10.1016/j.ejso.2018.02.007. Epub 2018 Feb 14. Review.

PMID:
29478741
25.

Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models.

Saunders KO, Verkoczy LK, Jiang C, Zhang J, Parks R, Chen H, Housman M, Bouton-Verville H, Shen X, Trama AM, Scearce R, Sutherland L, Santra S, Newman A, Eaton A, Xu K, Georgiev IS, Joyce MG, Tomaras GD, Bonsignori M, Reed SG, Salazar A, Mascola JR, Moody MA, Cain DW, Centlivre M, Zurawski S, Zurawski G, Erickson HP, Kwong PD, Alam SM, Levy Y, Montefiori DC, Haynes BF.

Cell Rep. 2017 Dec 26;21(13):3681-3690. doi: 10.1016/j.celrep.2017.12.028.

26.

Benefits and Risks of Machine Learning Decision Support Systems.

Licitra L, Trama A, Hosni H.

JAMA. 2017 Dec 19;318(23):2354. doi: 10.1001/jama.2017.16627. No abstract available.

27.

Structure and Diversity of the Rhesus Macaque Immunoglobulin Loci through Multiple De Novo Genome Assemblies.

Ramesh A, Darko S, Hua A, Overman G, Ransier A, Francica JR, Trama A, Tomaras GD, Haynes BF, Douek DC, Kepler TB.

Front Immunol. 2017 Oct 27;8:1407. doi: 10.3389/fimmu.2017.01407. eCollection 2017.

28.

Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.

Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA; RARECARENet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):67-74. doi: 10.1016/j.ejso.2017.09.025. Epub 2017 Nov 3. Review.

PMID:
29108961
29.

Epidemiology of rare cancers and inequalities in oncologic outcomes.

Gatta G, Trama A, Capocaccia R; RARECARENet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):3-11. doi: 10.1016/j.ejso.2017.08.018. Epub 2017 Sep 19.

PMID:
29032924
30.

Treatment challenges in and outside a network setting: Soft tissue sarcomas.

Pasquali S, Bonvalot S, Tzanis D, Casali PG, Trama A, Gronchi A; RARECARENet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):31-39. doi: 10.1016/j.ejso.2017.09.015. Epub 2017 Sep 19.

PMID:
28985973
31.

Trends in lung cancer and smoking behavior in Italy: an alarm bell for women.

Trama A, Boffi R, Contiero P, Buzzoni C, Pacifici R, Mangone L; AIRTUM Working Group.

Tumori. 2017 Nov 23;103(6):543-550. doi: 10.5301/tj.5000684. Epub 2017 Sep 21.

32.

Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study.

Minicozzi P, Innos K, Sánchez MJ, Trama A, Walsh PM, Marcos-Gragera R, Dimitrova N, Botta L, Visser O, Rossi S, Tavilla A, Sant M; EUROCARE-5 Working Group.

Eur J Cancer. 2017 Oct;84:335-353. doi: 10.1016/j.ejca.2017.07.015. Epub 2017 Sep 1.

PMID:
28865261
33.

HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces gp41 Antibody Immunodominance in Rhesus Macaques.

Han Q, Williams WB, Saunders KO, Seaton KE, Wiehe KJ, Vandergrift N, Von Holle TA, Trama AM, Parks RJ, Luo K, Gurley TC, Kepler TB, Marshall DJ, Montefiori DC, Sutherland LL, Alam MS, Whitesides JF, Bowman CM, Permar SR, Graham BS, Mascola JR, Seed PC, Van Rompay KKA, Tomaras GD, Moody MA, Haynes BF.

J Virol. 2017 Oct 13;91(21). pii: e00923-17. doi: 10.1128/JVI.00923-17. Print 2017 Nov 1.

34.

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.

Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, Comber H, Dimitrova N, Leinonen MK, Siesling S, van der Zwan JM, Van Eycken L, Visser O, Žakelj MP, Anderson LA, Bella F, Kaire I, Otter R, Stiller CA, Trama A; RARECAREnet working group.

Lancet Oncol. 2017 Aug;18(8):1022-1039. doi: 10.1016/S1470-2045(17)30445-X. Epub 2017 Jul 4. Erratum in: Lancet Oncol. 2017 Aug;18(8):e433.

PMID:
28687376
35.

Improving treatment results with reference centres for rare cancers: where do we stand?

Ray-Coquard I, Pujade Lauraine E, Le Cesne A, Pautier P, Vacher Lavenue MC, Trama A, Casali P, Coindre JM, Blay JY.

Eur J Cancer. 2017 May;77:90-98. doi: 10.1016/j.ejca.2017.02.006. Epub 2017 Apr 3. Review.

PMID:
28384534
36.

Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies.

Bonsignori M, Kreider EF, Fera D, Meyerhoff RR, Bradley T, Wiehe K, Alam SM, Aussedat B, Walkowicz WE, Hwang KK, Saunders KO, Zhang R, Gladden MA, Monroe A, Kumar A, Xia SM, Cooper M, Louder MK, McKee K, Bailer RT, Pier BW, Jette CA, Kelsoe G, Williams WB, Morris L, Kappes J, Wagh K, Kamanga G, Cohen MS, Hraber PT, Montefiori DC, Trama A, Liao HX, Kepler TB, Moody MA, Gao F, Danishefsky SJ, Mascola JR, Shaw GM, Hahn BH, Harrison SC, Korber BT, Haynes BF.

Sci Transl Med. 2017 Mar 15;9(381). pii: eaai7514. doi: 10.1126/scitranslmed.aai7514.

37.

Changes in mortality and incidence of prostate cancer by risk class in different periods in Italy: the possible effects of PSA spread.

Vicentini M, Sacchettini C, Trama A, Nicolai N, Gatta G, Botta L, Valdagni R, Giorgi Rossi P; Prostate Cancer High-Resolution Study Working Group.

Tumori. 2017 May 12;103(3):292-298. doi: 10.5301/tj.5000613. Epub 2017 Feb 28.

PMID:
28291906
38.

Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols.

Ferrari A, Trama A, De Paoli A, Bergeron C, Merks JHM, Jenney M, Orbach D, Chisholm JC, Gallego S, Glosli H, De Salvo GL, Botta L, Gatta G, Bisogno G; RARECAREnet Working Group.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26348. Epub 2016 Nov 24.

PMID:
27882658
39.

Data quality in rare cancers registration: the report of the RARECARE data quality study.

Trama A, Marcos-Gragera R, Sánchez Pérez MJ, van der Zwan JM, Ardanaz E, Bouchardy C, Melchor JM, Martinez C, Capocaccia R, Vicentini M, Siesling S, Gatta G; RARECARE working group contributing to the data quality study.

Tumori. 2017 Jan 21;103(1):22-32. doi: 10.5301/tj.5000559. Epub 2016 Oct 3.

PMID:
27716878
40.

Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity.

Bradley T, Trama A, Tumba N, Gray E, Lu X, Madani N, Jahanbakhsh F, Eaton A, Xia SM, Parks R, Lloyd KE, Sutherland LL, Scearce RM, Bowman CM, Barnett S, Abdool-Karim SS, Boyd SD, Melillo B, Smith AB 3rd, Sodroski J, Kepler TB, Alam SM, Gao F, Bonsignori M, Liao HX, Moody MA, Montefiori D, Santra S, Morris L, Haynes BF.

EBioMedicine. 2016 Oct;12:196-207. doi: 10.1016/j.ebiom.2016.08.045. Epub 2016 Aug 31.

41.

Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study.

Trama A, Botta L, Nicolai N, Rossi PG, Contiero P, Fusco M, Lodde M, Pannozzo F, Piffer S, Puppo A, Seeber A, Tumino R, Valdagni R, Gatta G; Prostate Cancer High Resolution Study Working Group.

Eur J Cancer. 2016 Nov;67:91-98. doi: 10.1016/j.ejca.2016.07.021. Epub 2016 Sep 10.

PMID:
27620947
42.

Personalise Medicine, Do Not Medicalise Persons: The Case of Patients with Stage I Testis Tumour Undergoing Surveillance.

Nicolai N, Trama A.

Eur Urol. 2017 Jan;71(1):128-129. doi: 10.1016/j.eururo.2016.08.069. Epub 2016 Sep 7. No abstract available.

PMID:
27614694
43.

Accreditation for centers of sarcoma surgery.

Sandrucci S, Trama A, Quagliuolo V, Gronchi A.

Updates Surg. 2017 Mar;69(1):1-7. doi: 10.1007/s13304-016-0382-z. Epub 2016 Aug 8.

PMID:
27502605
44.

Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virus.

Zhang R, Martinez DR, Nguyen QN, Pollara J, Arifin T, Stolarchuk C, Foulger A, Amos JD, Parks R, Himes JE, Wang M, Edwards RW, Trama AM, Vandergrift N, Colvin L, Dewar K, Juretic N, Wasserscheid J, Ferrari G, Liao HX, Permar SR.

Nat Commun. 2016 Jul 6;7:12131. doi: 10.1038/ncomms12131.

45.

Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5.

Trama A, Botta L, Foschi R, Ferrari A, Stiller C, Desandes E, Maule MM, Merletti F, Gatta G; EUROCARE-5 Working Group.

Lancet Oncol. 2016 Jul;17(7):896-906. doi: 10.1016/S1470-2045(16)00162-5. Epub 2016 May 26.

46.

Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages.

Zhang R, Verkoczy L, Wiehe K, Munir Alam S, Nicely NI, Santra S, Bradley T, Pemble CW 4th, Zhang J, Gao F, Montefiori DC, Bouton-Verville H, Kelsoe G, Larimore K, Greenberg PD, Parks R, Foulger A, Peel JN, Luo K, Lu X, Trama AM, Vandergrift N, Tomaras GD, Kepler TB, Moody MA, Liao HX, Haynes BF.

Sci Transl Med. 2016 Apr 27;8(336):336ra62. doi: 10.1126/scitranslmed.aaf0618.

47.

Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Erratum in: Epidemiol Prev. 2016 Mar-Apr;40(2):83.

48.

Diagnosis and management of typical and atypical lung carcinoids.

Pusceddu S, Lo Russo G, Macerelli M, Proto C, Vitali M, Signorelli D, Ganzinelli M, Scanagatta P, Duranti L, Trama A, Buzzoni R, Pelosi G, Pastorino U, de Braud F, Garassino MC.

Crit Rev Oncol Hematol. 2016 Apr;100:167-76. doi: 10.1016/j.critrevonc.2016.02.009. Epub 2016 Feb 18. Review.

PMID:
26917456
49.

Thymoma and thymic carcinomas.

Scorsetti M, Leo F, Trama A, D'Angelillo R, Serpico D, Macerelli M, Zucali P, Gatta G, Garassino MC.

Crit Rev Oncol Hematol. 2016 Mar;99:332-50. doi: 10.1016/j.critrevonc.2016.01.012. Epub 2016 Jan 19. Review.

PMID:
26818050
50.

Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?

Signorelli D, Macerelli M, Proto C, Vitali M, Cona MS, Agustoni F, Zilembo N, Platania M, Trama A, Gallucci R, Ganzinelli M, Pelosi G, Pastorino U, de Braud F, Garassino MC, Lo Russo G.

Tumori. 2016 Jan-Feb;102(1):18-30. doi: 10.5301/tj.5000436. Epub 2015 Oct 14. Review.

PMID:
26481865

Supplemental Content

Support Center